Showing results (291-300 of 1,142) with videos related to

Sort By:
Pageof 115
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 16, 2016
Liver transplantation in GermanyFrank Tacke, Daniela C Kroy, Ana Paula Barreiros, et al.
Cells|May 30, 2019
Single Cell RNA Sequencing Identifies Subsets of Hepatic Stellate Cells and Myofibroblasts in Liver FibrosisOliver Krenkel, Jana Hundertmark, Thomas P Ritz, et al.
International Journal of Molecular Sciences|October 2, 2019
The Role of Adipokines as Circulating Biomarkers in Critical Illness and SepsisSven H Loosen, Alexander Koch, Frank Tacke, et al.
Critical Care (London, England)|June 24, 2009
Serum resistin levels in critically ill patients are associated with inflammation, organ dysfunction and metabolism and may predict survival of non-septic patientsAlexander Koch, Olav A Gressner, Edouard Sanson, et al.
Diabetes Care|March 6, 2007
Insulin resistance in liver cirrhosis is not associated with circulating retinol-binding protein 4Eray Yagmur, Ralf Weiskirchen, Axel M Gressner, et al.
BMC Immunology|June 23, 2010
Age-dependent alterations of monocyte subsets and monocyte-related chemokine pathways in healthy adultsSebastian Seidler, Henning W Zimmermann, Matthias Bartneck, et al.
Hepatology (Baltimore, Md.)|July 10, 2019
Report on the AASLD/EASL Joint Workshop on Clinical Trial Endpoints in NAFLDMary E Rinella, Frank Tacke, Arun J Sanyal, et al.
Frontiers in Medicine|February 18, 2026
Intestinal permeability correlated with chronic fatigue in a patient with long COVID-A case report and overview of the literatureIngo Andus, Janine Büttner, Bettina Bochow-Fitzner, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 5, 2020
Covert hepatic encephalopathy and spontaneous portosystemic shunts increase the risk of developing overt hepatic encephalopathyRobin Greinert, Alexander Zipprich, Macarena Simón-Talero, et al.
Hepatology (Baltimore, Md.)|November 22, 2013
Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic ratsLen Verbeke, Ricard Farre, Jonel Trebicka, et al.
Pageof 115